v Promotes joint health, mobility and overall joint comfort*
v Supports cartilage health with undenatured type II collagen, hyaluronic acid and MSM*
v Promotes joint flexibility and comfort with UC-II® cartilage containing collagen*
- In a randomized, double-blind trial involving 52 subjects, 40 mg of UC-II® was more than twice as effective in promoting joint health as 1,500 mg of glucosamine and 1,200 mg of chondroitin as rated by WOMAC, VAS and the Lequesne functional index*
- A human pilot study involving five women supplemented with 40 mg of UC-II® for 42 days indicates statistically significant support for joint comfort and flexibility*
v Supports tissue hydration and joint lubrication with low molecular weight hyaluronic acid*
- In a pharmacokinetic study, orally administered HyaMax®hyaluronic acid was incorporated into joints, connective tissue and skin, with a particular affinity for cartilaginous joints*
v Maintains healthy 5-lipoxygenase and cyclooxygenase-2 enzyme activity and cytokine metabolism to support joint comfort with 5-LOXIN® AKBA boswellia and enhanced absorption Meriva® turmeric extracts*
Joint Complex (single dose)* supports joint function and comfort with cartilage building blocks and herbal extracts in convenient one-per-day dosing.
UC-II® is a trademark of InterHealth N.I. UC-II® brand of undenatured type II collagen (U. S. Patents 5,645,851, 5,637,321, 5,529,786, 5,750,144, 7,083,820, EPO Patent EP1435906B1, Canadian Patent CA2459981L, Japanese Patent JP 4,800,574B2 and world-wide patents pending).
OptiMSM® is a registered trademark of Bergstrom Nutrition.
Meriva® is a trademark of Indena S.p.A.
Phytosome More Bioavailable is a trademark of Indena S.p.A.
HyaMax® is a U.S.A. registered trademark of Fenchem
5-LOXIN® is a registered trademark of PL Thomas – Laila Nutra, LLC and is used under license. International Patents Pending.